Viveve Med (VIVE) Stock Price, News & Analysis
Company Description
Viveve Med (OTC Link: VIVE) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $4.3K.
VIVE has gained 100.0% over the past year. Shares last traded at $0.0002.
This page collects what Stock Titan holds for VIVE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Viveve Med (VIVE) stock last closed at $0.0002. Over the past 12 months, the stock has gained 100.0%. At a market capitalization of $4.3K, VIVE is classified as a micro-cap stock with approximately 10.7M shares outstanding.
Latest News
Viveve Med has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, conferences. View all VIVE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Viveve Med (VIVE) currently stands at 2.9 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Viveve Med (VIVE) currently stands at 2.8 days, up 102.2% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 175% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.0 days.
VIVE Company Profile & Sector Positioning
Viveve Med (VIVE) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing VIVE often look at related companies in the same sector, including Pressure Bio (PBIO), Nemaura Med Inc (NMRD), Biolase Inc (BIOLQ), Thermogenesis Holdings Inc (THMO), and TRANSLATE BIO, INC. (TBIO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VIVE's relative position within its industry.